menu
    • menu

    Find Pimavanserin Tartrate manufacturers, exporters & distributors on PharmaCompass

    polpharma Pimavanserin Tartrate

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    20

    API Suppliers

    API Suppliers

    7

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    1

    EU WC

    EU WC

    0

    KDMF

    KDMF

    5

    NDC API

    NDC API

    0

    VMF

    NDC API

    14

    Listed Suppliers

    Other Suppliers

    1INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    19

    Others

    FINISHED DOSAGE FORMULATIONS

    8

    FDF Dossiers

    FDF Dossiers

    8

    FDA Orange Book

    FDA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    26DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    77RELATED EXCIPIENT COMPANIES

    126EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    18

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 2,946

    GLOBAL SALES INFORMATION

    US Medicaid

    595,675,170

    Annual Reports

    NA

    Regulatory FDF Prices

    NA

    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    4

    API

    0

    FDF

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    60

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 706779-91-1, Acp-103, 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea, Pimavanserin [inn], Pimavanserin free base, Jz963p0dik
    Molecular Formula
    C25H34FN3O2
    Molecular Weight
    427.6  g/mol
    InChI Key
    RKEWSXXUOLRFBX-UHFFFAOYSA-N
    FDA UNII
    JZ963P0DIK
    Pimavanserin Tartrate
    Psychotic symptoms associated with Parkinson's disease (PD) are relatively common, reducing quality of life and prognosis for individuals with PD. Pimavanserin (ACP-103), marketed under the trade name Nuplazid, is a drug developed by Acadia Pharmaceuticals for the treatment of psychosis related to Parkinson's disease. Due to its actions at serotonin receptors and lack of effects on dopamine receptors, pimavanserin treats hallucinations and delusions without causing extrapyramidal symptoms. It was initially approved by the FDA in 2016 and is now under review as a potential treatment for dementia related psychosis. As of April 2021, FDA approval has not been granted for this indication, despite previous breakthrough designation.
    Pimavanserin is an Atypical Antipsychotic.
    1 2D Structure

    Pimavanserin Tartrate

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
    2.1.2 InChI
    InChI=1S/C25H34FN3O2/c1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21/h4-11,19,23H,12-18H2,1-3H3,(H,27,30)
    2.1.3 InChI Key
    RKEWSXXUOLRFBX-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C
    2.2 Other Identifiers
    2.2.1 UNII
    JZ963P0DIK
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Acp 103

    2. Acp-103

    3. Acp103

    4. Bis(1-(4-fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-(4-(2-methylpropoxy)benzyl)urea) (2r,3r)-2,3-dihydroxybutanedioate

    5. N-(4-fluorophenylmethyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide

    6. Nuplazid

    7. Pimavanserin Tartrate

    8. Urea, N-((4-fluorophenyl)methyl)-n-(1-methyl-4-piperidinyl)-n'-((4-(2-methylpropoxy)phenyl)methyl)-, (2r,3r)-2,3-dihydroxybutanedioate (2:1)

    2.3.2 Depositor-Supplied Synonyms

    1. 706779-91-1

    2. Acp-103

    3. 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea

    4. Pimavanserin [inn]

    5. Pimavanserin Free Base

    6. Jz963p0dik

    7. 706779-91-1 (free Base)

    8. 1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea

    9. N-(4-fluorophenylmethyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl) Carbamide

    10. Unii-jz963p0dik

    11. N-(4-fluorophenylmethyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide

    12. 706782-28-7

    13. Pimanavserin

    14. Methyltrimethylacetate

    15. Ac-5273

    16. Pimavanserin [mi]

    17. Pimavanserin(acp-103)

    18. Pimavanserin [who-dd]

    19. Schembl675165

    20. Nuplazid (proposed Trade Name)

    21. Gtpl8423

    22. Chembl2111101

    23. Dtxsid90990906

    24. Chebi:133017

    25. Bdbm139370

    26. Hms3742a03

    27. Bcp11618

    28. Ex-a4895

    29. Mfcd09953792

    30. Zinc16159083

    31. Akos015902593

    32. Cs-3378

    33. Db05316

    34. Me-0240

    35. Sb16963

    36. Ncgc00390656-01

    37. Ncgc00390656-02

    38. Hy-14557

    39. B8019

    40. Ft-0653701

    41. A14434

    42. 779p911

    43. A836958

    44. J-503297

    45. Q7194603

    46. N-[(4-fluorophenyl)methyl]-n-(1-methyl-4-piperidinyl)-n'-[[4-(2-methylpropoxy)phenyl]methyl]urea;

    47. N-[(4-fluorophenyl)methyl]-n-(1-methylpiperidin-4-yl)-n'-{[4-(2-methylpropoxy)phenyl]methyl}urea

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 427.6 g/mol
    Molecular Formula C25H34FN3O2
    XLogP34.5
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count8
    Exact Mass427.26350550 g/mol
    Monoisotopic Mass427.26350550 g/mol
    Topological Polar Surface Area44.8 Ų
    Heavy Atom Count31
    Formal Charge0
    Complexity523
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Pimavanserin is indicated for the treatment of hallucinations and delusions associated with Parkinsons disease psychosis.

    Treatment of schizophrenia and other psychotic disorders

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Pimavanserin's unique actions on serotonin receptors improve symptoms of hallucinations and delusions associated with Parkinson's disease. In clinical studies, 80.5% of individuals treated with pimavanserin reported improvement in symptoms. Pimavanserin does not worsen motor functioning in patients with Parkinson's disease psychosis.

    5.2 MeSH Pharmacological Classification

    Antiparkinson Agents

    Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)

    Antipsychotic Agents

    Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)

    Serotonin 5-HT2 Receptor Antagonists

    Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes. (See all compounds classified as Serotonin 5-HT2 Receptor Antagonists.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    PIMAVANSERIN
    5.3.2 FDA UNII
    JZ963P0DIK
    5.3.3 Pharmacological Classes
    Established Pharmacologic Class [EPC] - Atypical Antipsychotic
    5.4 ATC Code

    N - Nervous system

    N05 - Psycholeptics

    N05A - Antipsychotics

    N05AX - Other antipsychotics

    N05AX17 - Pimavanserin

    5.5 Absorption, Distribution and Excretion

    Absorption

    The median Tmax of pimavanserin in clinical studies was 6 hours, regardless of the dose. Bioavailability of an oral tablet of pimavanserin and a solution were almost identical. The major active circulating N-desmethylated metabolite, AC-279, has a median Tmax of 6 hours.

    Route of Elimination

    About 0.55% of a 34 mg oral dose was excreted unchanged in the urine and 1.53% was eliminated in feces within 10 days. Less than 1% of the administered dose and its active metabolite AC-279 were recovered in urine during clinical studies.

    Volume of Distribution

    Following administration of a single dose of 34 mg, the average apparent volume of distribution was 2173 L in clinical studies.

    5.6 Metabolism/Metabolites

    Pimavanserin is mainly metabolized CYP3A4 and CYP3A5 hepatic cytochrome enzymes, and to a lesser extent by CYP2J2, CYP2D6, and other cytochrome and flavin-containing monooxygenase enzymes. CYP3A4 metabolizes pimavanserin to its major active metabolite, AC-279.

    5.7 Biological Half-Life

    The average plasma half-lives for pimavanserin and its active metabolite (AC-279) are estimated at 57 hours and 200 hours, respectively.

    5.8 Mechanism of Action

    Parkinson's disease psychosis (PDP) is a imbalance of serotonin and dopamine from disruption of the normal balance between the serotonergic and dopaminergic receptors and neurotransmitters in the brain. The mechanism by which pimavanserin treats hallucinations and delusions associated with Parkinsons disease psychosis is not fully established. It is possible that pimavanserin acts via inverse agonist and antagonist activity at serotonin 5-HT2A receptors with limited effects on serotonin 5-HT2C receptors. Pimavanserin is an inverse agonist and antagonist of serotonin 5-HT2A receptors with high binding affinity, demonstrating low binding affinity to serotonin 5-HT2C receptors. In addition, this drug exhibits low affinity binding to sigma 1 receptors. Pimavanserin lacks activity at muscarinic, dopaminergic, adrenergic, and histaminergic receptors, preventing various undesirable effects typically associated with antipsychotics.

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684953000,"product":"MSN PHARMACEUTICAL PRODUCT NAME PIMAVANSERIN TARTRATE II","address":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD","city":"HYDERABAD TS","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"RENATA LTD","customerCountry":"BANGLADESH","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"14000","totalValueFC":"3463.6","currency":"USD","unitRateINR":1140000,"date":"25-May-2023","totalValueINR":"285000","totalValueInUsd":"3463.6","indian_port":"HYDERABAD AIR","hs_no":"29333200","bill_no":"0","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD, HYDERABAD TS","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1687199400,"product":"PIMAVANSERIN TARTRATE","address":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIOS BAGO S A","customerCountry":"ARGENTINA","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"1750","totalValueFC":"13382.6","currency":"USD","unitRateINR":137499.96487500001,"date":"20-Jun-2023","totalValueINR":"1099999.719","totalValueInUsd":"13382.6","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"0","productDescription":"API","marketType":"","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689791400,"product":"PIMAVANSERIN TARTRATE","address":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"UNDISCLOSED","customerCountry":"TURKEY","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"10000","totalValueFC":"2482.1","currency":"USD","unitRateINR":815999.18400000001,"date":"20-Jul-2023","totalValueINR":"203999.796","totalValueInUsd":"2482.1","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"0","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722882600,"product":"PIMAVANSERIN TARTRATE","address":"8-3-166\/182, A BLOCK, NORTH WING,,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"MONTEVIDEO -","customer":"MEGA LABS S A","customerCountry":"URUGUAY","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"3200","totalValueFC":"5891.1","currency":"USD","unitRateINR":247070,"date":"06-Aug-2024","totalValueINR":"494140","totalValueInUsd":"5891.1","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"2994633","productDescription":"API","marketType":"","country":"URUGUAY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,,, ERRADADDA,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1743186600,"product":"PIMAVANSERIN TARTRATE","address":"8-3-166\/182, A BLOCK, NORTH WING,,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"QUIMICA ARISTON SAIC","customerCountry":"ARGENTINA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"36666.7","totalValueFC":"10540.6","currency":"USD","unitRateINR":3043333.3333333335,"date":"29-Mar-2025","totalValueINR":"913000","totalValueInUsd":"10540.6","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"9491767","productDescription":"API","marketType":"","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,,, ERRADADDA,TELANGANA","customerAddress":""}]
    25-May-2023
    29-Mar-2025
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API/FDF Prices: Book a Demo to explore the features and consider upgrading later

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Granulation

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Topical

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Looking for 706779-91-1 / Pimavanserin Tartrate API manufacturers, exporters & distributors?

    Pimavanserin Tartrate manufacturers, exporters & distributors 1

    52

    PharmaCompass offers a list of Pimavanserin Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pimavanserin Tartrate manufacturer or Pimavanserin Tartrate supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pimavanserin Tartrate manufacturer or Pimavanserin Tartrate supplier.

    PharmaCompass also assists you with knowing the Pimavanserin Tartrate API Price utilized in the formulation of products. Pimavanserin Tartrate API Price is not always fixed or binding as the Pimavanserin Tartrate Price is obtained through a variety of data sources. The Pimavanserin Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Pimavanserin Tartrate

    Synonyms

    706779-91-1, Acp-103, 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea, Pimavanserin [inn], Pimavanserin free base, Jz963p0dik

    Cas Number

    706779-91-1

    Unique Ingredient Identifier (UNII)

    JZ963P0DIK

    About Pimavanserin Tartrate

    Psychotic symptoms associated with Parkinson's disease (PD) are relatively common, reducing quality of life and prognosis for individuals with PD. Pimavanserin (ACP-103), marketed under the trade name Nuplazid, is a drug developed by Acadia Pharmaceuticals for the treatment of psychosis related to Parkinson's disease. Due to its actions at serotonin receptors and lack of effects on dopamine receptors, pimavanserin treats hallucinations and delusions without causing extrapyramidal symptoms. It was initially approved by the FDA in 2016 and is now under review as a potential treatment for dementia related psychosis. As of April 2021, FDA approval has not been granted for this indication, despite previous breakthrough designation.

    ACP 103 Manufacturers

    A ACP 103 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ACP 103, including repackagers and relabelers. The FDA regulates ACP 103 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ACP 103 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of ACP 103 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    ACP 103 Suppliers

    A ACP 103 supplier is an individual or a company that provides ACP 103 active pharmaceutical ingredient (API) or ACP 103 finished formulations upon request. The ACP 103 suppliers may include ACP 103 API manufacturers, exporters, distributors and traders.

    click here to find a list of ACP 103 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    ACP 103 USDMF

    A ACP 103 DMF (Drug Master File) is a document detailing the whole manufacturing process of ACP 103 active pharmaceutical ingredient (API) in detail. Different forms of ACP 103 DMFs exist exist since differing nations have different regulations, such as ACP 103 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A ACP 103 DMF submitted to regulatory agencies in the US is known as a USDMF. ACP 103 USDMF includes data on ACP 103's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ACP 103 USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of ACP 103 suppliers with USDMF on PharmaCompass.

    ACP 103 WC

    A ACP 103 written confirmation (ACP 103 WC) is an official document issued by a regulatory agency to a ACP 103 manufacturer, verifying that the manufacturing facility of a ACP 103 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting ACP 103 APIs or ACP 103 finished pharmaceutical products to another nation, regulatory agencies frequently require a ACP 103 WC (written confirmation) as part of the regulatory process.

    click here to find a list of ACP 103 suppliers with Written Confirmation (WC) on PharmaCompass.

    ACP 103 NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ACP 103 as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for ACP 103 API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture ACP 103 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain ACP 103 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ACP 103 NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of ACP 103 suppliers with NDC on PharmaCompass.

    ACP 103 GMP

    ACP 103 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of ACP 103 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ACP 103 GMP manufacturer or ACP 103 GMP API supplier for your needs.

    ACP 103 CoA

    A ACP 103 CoA (Certificate of Analysis) is a formal document that attests to ACP 103's compliance with ACP 103 specifications and serves as a tool for batch-level quality control.

    ACP 103 CoA mostly includes findings from lab analyses of a specific batch. For each ACP 103 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    ACP 103 may be tested according to a variety of international standards, such as European Pharmacopoeia (ACP 103 EP), ACP 103 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ACP 103 USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search